Back to Search
Start Over
Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.
- Source :
-
Evidence-based Complementary & Alternative Medicine (eCAM) . 7/7/2021, p1-15. 15p. 1 Chart, 9 Graphs. - Publication Year :
- 2021
-
Abstract
- Introduction. Osteosarcoma is a malignant tumor associated with high mortality rates due to the toxic side effects of current therapeutic methods. Tanshinone IIA can inhibit cell proliferation and promote apoptosis in vitro, but the exact mechanism is still unknown. The aims of this study are to explore the antiosteosarcoma effect of tanshinone IIA via Src kinase and demonstrate the mechanism of this effect. Materials and Methods. Osteosarcoma MG-63 and U2-OS cell lines were stable transfections with Src-shRNA. Then, the antiosteosarcoma effect of tanshinone IIA was tested in vitro. The protein expression levels of Src, p-Src, p-ERK1/2, and p-AKt were detected by Western blot and RT-PCR. CCK-8 assay and BrdU immunofluorescence assay were used to detect cell proliferation. Transwell assay, cell scratch assay, and flow cytometry were used to detect cell invasion, migration, and cell cycle. Tumor-bearing nude mice with osteosarcoma were constructed. The effect of tanshinone IIA was detected by tumor HE staining, tumor inhibition rate, incidence of lung metastasis, and X-ray. Results. The oncogene role of Src kinase in osteosarcoma is reflected in promoting cell proliferation, invasion, and migration and in inhibiting apoptosis. However, Src has different effects on cell proliferation, apoptosis, and cell cycle regulation among cell lines. At a cellular level, the antiosteosarcoma effect of tanshinone IIA is mediated by Src downstream of the MAPK/ERK and PI3K/AKt signaling pathways. At the animal level, tanshinone IIA played a role in resisting osteosarcoma formation by Src downstream of the MAPK/ERK and PI3K/AKt signaling pathways. Conclusion. Tanshinone IIA plays an antiosteosarcoma role in vitro and in vivo and inhibits the progression of osteosarcoma mediated by Src downstream of the MAPK/ERK and PI3K/AKt signaling pathways. [ABSTRACT FROM AUTHOR]
- Subjects :
- *PROTEIN metabolism
*IN vitro studies
*REVERSE transcriptase polymerase chain reaction
*DISEASE progression
*FLOW cytometry
*HERBAL medicine
*STAINS & staining (Microscopy)
*OSTEOSARCOMA
*ANIMAL experimentation
*WESTERN immunoblotting
*FLUOROIMMUNOASSAY
*CANCER invasiveness
*ANTINEOPLASTIC agents
*RNA
*LUNG tumors
*APOPTOSIS
*DISEASE incidence
*HYDROCARBONS
*TREATMENT effectiveness
*CELL motility
*CELL cycle
*CELLULAR signal transduction
*TRANSFERASES
*CELL proliferation
*POLYMERASE chain reaction
*CELL lines
*CHINESE medicine
*MICE
*PHARMACODYNAMICS
Subjects
Details
- Language :
- English
- ISSN :
- 1741427X
- Database :
- Academic Search Index
- Journal :
- Evidence-based Complementary & Alternative Medicine (eCAM)
- Publication Type :
- Academic Journal
- Accession number :
- 151269774
- Full Text :
- https://doi.org/10.1155/2021/5563691